Lapatinib Ditosylate

Lapatinib Ditosylate

14000 INR

Product Details:

  • Drug Type Specific Drug
  • Physical Form Tablets
  • Function Anti-Cancer
  • Suitable For Adults
  • Storage Instructions Dry Place
  • Supply Ability : 1 Piece Crore Per Week
  • Click to view more
X

Price And Quantity

  • 14000 INR
  • 1 Crore Piece

Product Specifications

  • Specific Drug
  • Adults
  • Dry Place
  • Tablets
  • Anti-Cancer

Trade Information

  • Cash in Advance (CID), Cash Advance (CA)
  • 1 Piece Crore Per Week
  • 1 Week
  • Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia

Product Description

Lapatinib Ditosylate Tablet

Lapatinib is an anti-cancer drug used as a treatment for solid tumours such as breast and lung cancer. It was approved by the FDA on March 13, 2007, for use in patients with advanced metastatic breast cancer in conjunction with the chemotherapy drug Capecitabine. Lapatinib is human epidermal growth factor receptor type 2 (HER2/ERBB2) and epidermal growth factor receptor (HER1/EGFR/ERBB1) tyrosine kinases inhibitor. It binds to the intracellular phosphorylation domain to prevent receptor autophosphorylation upon ligand binding.

Features:

  • Utmost effectiveness
  • Treats advanced breast cancer
  • Precise composition
  • Accurate level of pH

DHEER HEALTHCARE PRIVATE LIMITED

* Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.



DHEER HEALTHCARE PRIVATE LIMITED All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Ltd.